Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you ever treat regional lymph nodes for malignant phyllodes tumor of the breast?
In what situations would you want to include regional nodes? Particular tumor size?
Answer from: Radiation Oncologist at Community Practice
I have not treated regional nodes in malignant phyllodes cases, even in larger tumors.
Sign in or Register to read more
10764
Related Questions
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
Would you consider omitting adjuvant radiation in a very elderly patient with a small triple negative breast cancer?
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
Is it appropriate to use bolus with hypofractionated PMRT?
How do you approach breast hypofractionation RNI with the results of the Skagen Trial 1?
What are your top takeaways in Breast Cancer from ESMO 2024?